In our series consisting of RCC cases exhibiting significant malignant behavior, excluding oncocytomas, CD47 expression was detected in 57 out of 186 cases (30.6%), while expression was not observed in 129 cases (69.4%). The gene discussed is CD47; the disease is oncocytic adenoma.